Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 72 articles:
HTML format
Text format



Single Articles


    March 2017
  1. MORTON RL, Tran A, Vessey JY, Rowbotham N, et al
    Quality of Life Following Sentinel Node Biopsy for Primary Cutaneous Melanoma: Health Economic Implications.
    Ann Surg Oncol. 2017 Mar 20. doi: 10.1245/s10434-017-5842.
    PubMed     Text format     Abstract available


  2. DAVIS JL, Langan RC, Panageas KS, Zheng J, et al
    Elevated Blood Neutrophil-to-Lymphocyte Ratio: A Readily Available Biomarker Associated with Death due to Disease in High Risk Nonmetastatic Melanoma.
    Ann Surg Oncol. 2017 Mar 16. doi: 10.1245/s10434-017-5836.
    PubMed     Text format     Abstract available


    February 2017
  3. JONES MS, Jones PC, Stern SL, Elashoff D, et al
    The Impact of Smoking on Sentinel Node Metastasis of Primary Cutaneous Melanoma.
    Ann Surg Oncol. 2017 Feb 21. doi: 10.1245/s10434-017-5775.
    PubMed     Text format     Abstract available


  4. MADU MF, Deken MM, van der Hage JA, Jozwiak K, et al
    Isolated Limb Perfusion for Melanoma is Safe and Effective in Elderly Patients.
    Ann Surg Oncol. 2017 Feb 10. doi: 10.1245/s10434-017-5803.
    PubMed     Text format     Abstract available


    January 2017
  5. PARK TS, Phan GQ, Yang JC, Kammula U, et al
    Routine Computer Tomography Imaging for the Detection of Recurrences in High-Risk Melanoma Patients.
    Ann Surg Oncol. 2017 Jan 31. doi: 10.1245/s10434-017-5768.
    PubMed     Text format     Abstract available


  6. CROOKES TR, Scolyer RA, Lo S, Drummond M, et al
    Extranodal Spread is Associated with Recurrence and Poor Survival in Stage III Cutaneous Melanoma Patients.
    Ann Surg Oncol. 2017 Jan 27. doi: 10.1245/s10434-016-5723.
    PubMed     Text format     Abstract available


  7. BHUTIANI N, Egger ME, McMasters KM
    Optimizing Follow-up Assessment of Patients with Cutaneous Melanoma.
    Ann Surg Oncol. 2017 Jan 24. doi: 10.1245/s10434-017-5771.
    PubMed     Text format    


  8. STEWART CL, Gleisner A, Kwak J, Chapman B, et al
    Implications of Sentinel Lymph Node Drainage to Multiple Basins in Head and Neck Melanoma.
    Ann Surg Oncol. 2017 Jan 5. doi: 10.1245/s10434-016-5744.
    PubMed     Text format     Abstract available


    November 2016
  9. KARAKOUSIS G, Gimotty PA, Bartlett EK, Sim MS, et al
    Thin Melanoma with Nodal Involvement: Analysis of Demographic, Pathologic, and Treatment Factors with Regard to Prognosis.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  10. LEE AY, Droppelmann N, Panageas KS, Zhou Q, et al
    Patterns and Timing of Initial Relapse in Pathologic Stage II Melanoma Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    September 2016
  11. HAO H, Xiao D, Pan J, Qu J, et al
    Sentinel Lymph Node Genes to Predict Prognosis in Node-Positive Melanoma Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  12. FAUT M, Wevers KP, van Ginkel RJ, Diercks GF, et al
    Nodular Histologic Subtype and Ulceration are Tumor Factors Associated with High Risk of Recurrence in Sentinel Node-Negative Melanoma Patients.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  13. KLEMEN ND, Feingold PL, Goff SL, Hughes MS, et al
    Metastasectomy Following Immunotherapy with Adoptive Cell Transfer for Patients with Advanced Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  14. ENGELHARDT KE, Wayne JD, Bilimoria KY
    Editorial: Should We Abandon TNM Staging in Favor of Gene Profiles in Node-Positive Melanoma?
    Ann Surg Oncol. 2016.
    PubMed     Text format    


    August 2016
  15. LOVASIK BP, Sharma I, Russell MC, Carlson GW, et al
    Invasive Scalp Melanoma: Role for Enhanced Detection Through Professional Training.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  16. BELLO DM, Han G, Jackson L, Bulloch K, et al
    The Prognostic Significance of Sentinel Lymph Node Status for Patients with Thick Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  17. HEALY MA, Reynolds E, Banerjee M, Wong SL, et al
    Lymph Node Ratio Is Less Prognostic in Melanoma When Minimum Node Retrieval Thresholds Are Not Met.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  18. IPENBURG NA, Nieweg OE, Uren RF, Thompson JF, et al
    Outcome of Melanoma Patients Who Did Not Proceed to Sentinel Node Biopsy After Preoperative Lymphoscintigraphy.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    July 2016
  19. MOSQUERA C, Vora HS, Vohra N, Fitzgerald TL, et al
    Population-Based Analysis of Completion Lymphadenectomy in Intermediate-Thickness Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  20. LINO-SILVA LS, Dominguez-Rodriguez JA, Aguilar-Romero JM, Martinez-Said H, et al
    Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  21. MADU MF, Wouters MW, Klop WM, van der Hiel B, et al
    Clinical Prognostic Markers in Stage IIIB Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    June 2016
  22. KANDA M, Shimizu D, Fujii T, Tanaka H, et al
    Neurotrophin Receptor-Interacting Melanoma Antigen-Encoding Gene Homolog is Associated with Malignant Phenotype of Gastric Cancer.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  23. LORIMER PD, White RL, Walsh K, Han Y, et al
    Pediatric and Adolescent Melanoma: A National Cancer Data Base Update.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  24. ANDTBACKA RH, Ross M, Puzanov I, Milhem M, et al
    Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  25. MINAMI CA, Wayne JD, Yang AD, Martini MC, et al
    National Evaluation of Hospital Performance on the New Commission on Cancer Melanoma Quality Measures.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  26. SONDAK VK, Messina JL
    Prediction is Difficult, Especially About the Future: Clinical Prognostic Tools in Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  27. BURKE EE, Portschy PR, Tuttle TM, Kuntz KM, et al
    Completion Lymph Node Dissection or Observation for Melanoma Sentinel Lymph Node Metastases: A Decision Analysis.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  28. DAMUDE S, Hoekstra-Weebers JE, Francken AB, Ter Meulen S, et al
    The MELFO-Study: Prospective, Randomized, Clinical Trial for the Evaluation of a Stage-adjusted Reduced Follow-up Schedule in Cutaneous Melanoma Patients-Results after 1 Year.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    April 2016
  29. GE L, Vilain RE, Lo S, Aivazian K, et al
    Breslow Thickness Measurements of Melanomas Around American Joint Committee on Cancer Staging Cut-Off Points: Imprecision and Terminal Digit Bias Have Important Implications for Staging and Patient Management.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  30. MAHAR AL, Compton C, Halabi S, Hess KR, et al
    Critical Assessment of Clinical Prognostic Tools in Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    March 2016
  31. CHAPMAN BC, Gleisner A, Kwak JJ, Hosokawa P, et al
    SPECT/CT Improves Detection of Metastatic Sentinel Lymph Nodes in Patients with Head and Neck Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  32. DOEPKER MP, Thompson ZJ, Fisher KJ, Yamamoto M, et al
    Is a Wider Margin (2 cm vs. 1 cm) for a 1.01-2.0 mm Melanoma Necessary?
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  33. CORDEIRO E, Gervais MK, Shah PS, Look Hong NJ, et al
    Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    February 2016
  34. DOSSETT LA, Ben-Shabat I, Olofsson Bagge R, Zager JS, et al
    Clinical Response and Regional Toxicity Following Isolated Limb Infusion Compared with Isolated Limb Perfusion for In-Transit Melanoma.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  35. BAGGE AL, Ben-Shabat I, Belgrano V, Olofsson Bagge R, et al
    Erratum to: Health-Related Quality of Life for Patients Who have In-Transit Melanoma Metastases Treated with Isolated Limb Perfusion.
    Ann Surg Oncol. 2016.
    PubMed     Text format    


  36. VAN WISSEN J, van der Hiel B, van der Hage JA, van de Wiel BA, et al
    The Diagnostic Value of PET/CT Imaging in Melanoma Groin Metastases.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  37. ANNINGA B, White SH, Moncrieff M, Dziewulski P, et al
    Magnetic Technique for Sentinel Lymph Node Biopsy in Melanoma: The MELAMAG Trial.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


  38. BAGGE AL, Ben-Shabat I, Belgrano V, Bagge RO, et al
    Health-Related Quality of Life for Patients Who have In-Transit Melanoma Metastases Treated with Isolated Limb Perfusion.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    January 2016
  39. EGGER ME, Kimbrough CW, Stromberg AJ, Quillo AR, et al
    Melanoma Patient-Reported Quality of Life Outcomes Following Sentinel Lymph Node Biopsy, Completion Lymphadenectomy, and Adjuvant Interferon: Results from the Sunbelt Melanoma Trial.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available


    December 2015
  40. BEN-SHABAT I, Belgrano V, Ny L, Nilsson J, et al
    Long-Term Follow-Up Evaluation of 68 Patients with Uveal Melanoma Liver Metastases Treated with Isolated Hepatic Perfusion.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    November 2015
  41. HUGHES MS, Zager J, Faries M, Alexander HR, et al
    Results of a Randomized Controlled Multicenter Phase III Trial of Percutaneous Hepatic Perfusion Compared with Best Available Care for Patients with Melanoma Liver Metastases.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  42. RIBERO S, Osella-Abate S, Pasquali S, Rossi CR, et al
    Prognostic Role of Multiple Lymphatic Basin Drainage in Sentinel Lymph Node-Negative Trunk Melanoma Patients: A Multicenter Study from the Italian Melanoma Intergroup.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  43. LEE DY, Huynh KT, Teng A, Lau BJ, et al
    Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  44. KROON HM, Coventry BJ, Giles MH, Henderson MA, et al
    Australian Multicenter Study of Isolated Limb Infusion for Melanoma.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  45. BRYS AK, Bhatti L, Bashir MR, Jaffe TA, et al
    Computed Tomography-Based Limb Volume Measurements for Isolated Limb Infusion in Melanoma.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  46. MACKENZIE ROSS AD, Haydu LE, Quinn MJ, Saw RP, et al
    The Association Between Excision Margins and Local Recurrence in 11,290 Thin (T1) Primary Cutaneous Melanomas: A Case-Control Study.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  47. ROSS MI, Balch CM
    Excision Margins of Melanoma Make a Difference: New Data Support an Old Paradigm.
    Ann Surg Oncol. 2015.
    PubMed     Text format    


    October 2015
  48. GYORKI DE, Sanelli A, Herschtal A, Lazarakis S, et al
    Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification Tool.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    September 2015
  49. SMITH HG, Cartwright J, Wilkinson MJ, Strauss DC, et al
    Isolated Limb Perfusion with Melphalan and Tumour Necrosis Factor alpha for In-Transit Melanoma and Soft Tissue Sarcoma.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    July 2015
  50. DEPERALTA DK, Boland GM
    Melanoma: Advances in Targeted Therapy and Molecular Markers.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  51. BARTLETT EK, Peters MG, Blair A, Etherington MS, et al
    Identification of Patients with Intermediate Thickness Melanoma at Low Risk for Sentinel Lymph Node Positivity.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    May 2015
  52. COCHRAN AJ
    Identification, Clinical Significance, and Management of Very Small Melanoma Metastases in Sentinel Lymph Nodes.
    Ann Surg Oncol. 2015.
    PubMed     Text format    


  53. OUDE OPHUIS CM, van Akkooi AC, Hoekstra HJ, Bonenkamp JJ, et al
    Risk Factors for Positive Deep Pelvic Nodal Involvement in Patients with Palpable Groin Melanoma Metastases: Can the Extent of Surgery be Safely Minimized? : A Retrospective, Multicenter Cohort Study.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  54. HOLTKAMP LH, Wang S, Wilmott JS, Madore J, et al
    Detailed Pathological Examination of Completion Node Dissection Specimens and Outcome in Melanoma Patients with Minimal (<0.1 mm) Sentinel Lymph Node Metastases.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  55. MEMARI N, Hayen A, Bell KJ, Rychetnik L, et al
    How Often Do Patients with Localized Melanoma Attend Follow-Up at a Specialist Center?
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  56. HAYDU LE, Stollman JT, Scolyer RA, Spillane AJ, et al
    Minimum Safe Pathologic Excision Margins for Primary Cutaneous Melanomas (1-2 mm in Thickness): Analysis of 2131 Patients Treated at a Single Center.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  57. CAVANAUGH-HUSSEY MW, Mu EW, Kang S, Balch CM, et al
    Older Age is Associated with a Higher Incidence of Melanoma Death but a Lower Incidence of Sentinel Lymph Node Metastasis in the SEER Databases (2003-2011).
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    April 2015
  58. BALCH CM
    Decreased Survival Rates of Older-Aged Patients with Melanoma: Biological Differences or Undertreatment?
    Ann Surg Oncol. 2015.
    PubMed     Text format    


  59. SABEL MS, Kozminski D, Griffith K, Chang AE, et al
    Sentinel Lymph Node Biopsy Use Among Melanoma Patients 75 Years of Age and Older.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    March 2015
  60. MAKER AV, Iteld L
    Closure of Melanoma Defects on the Sole of the Foot Using Glaborous Skin: The End of the Flap?
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  61. KANDA M, Nomoto S, Oya H, Takami H, et al
    The Expression of Melanoma-Associated Antigen D2 Both in Surgically Resected and Serum Samples Serves as Clinically Relevant Biomarker of Gastric Cancer Progression.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  62. GOTTLIEB M, Balk SJ, Geller AC, Gershenwald JE, et al
    Teens and indoor tanning: time to act on the US Food and Drug Administration's black-box warning.
    Ann Surg Oncol. 2015;22:701-3.
    PubMed     Text format    


    February 2015
  63. LEITER U, Eigentler TK, Hafner HM, Krimmel M, et al
    Sentinel Lymph Node Dissection in Head and Neck Melanoma has Prognostic Impact on Disease-Free and Overall Survival.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  64. READ RL, Stalley P, Thompson JF
    The Contemporary Role of Major Amputation in the Management of Advanced Limb Melanoma.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    January 2015
  65. SPEIJERS MJ, Bastiaannet E, Sloot S, Suurmeijer AJ, et al
    Tumor Mitotic Rate Added to the Equation: Melanoma Prognostic Factors Changed? : A Single-Institution Database Study on the Prognostic Value of Tumor Mitotic Rate for Sentinel Lymph Node Status and Survival of Cutaneous Melanoma Patients.
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


  66. BARBOUR S, Mark Smithers B, Allan C, Bayley G, et al
    Patterns of Recurrence in Patients with Stage IIIB/C Cutaneous Melanoma of the Head and Neck Following Surgery With and Without Adjuvant Radiation Therapy: Is Isolated Regional Recurrence Salvageable?
    Ann Surg Oncol. 2015.
    PubMed     Text format     Abstract available


    December 2014
  67. HASSAN S, Petrella TM, Zhang T, Kamel-Reid S, et al
    Erratum to: Pathologic Complete Response to Intralesional Interleukin-2 Therapy Associated with Improved Survival in Melanoma Patients with In-Transit Disease.
    Ann Surg Oncol. 2014.
    PubMed     Text format    


  68. WASIF N, Etzioni D, Haddad D, Gray RJ, et al
    Staging Studies for Cutaneous Melanoma in the United States: A Population-Based Analysis.
    Ann Surg Oncol. 2014.
    PubMed     Text format     Abstract available


    November 2014
  69. JOOSSE A, van der Ploeg AP, Haydu LE, Nijsten TE, et al
    Sex Differences in Melanoma Survival are Not Related to Mitotic Rate of the Primary Tumor.
    Ann Surg Oncol. 2014.
    PubMed     Text format     Abstract available


  70. RIBERO S, Osella-Abate S, Sanlorenzo M, Balagna E, et al
    Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role?
    Ann Surg Oncol. 2014.
    PubMed     Text format     Abstract available


  71. SEIFRIED S, Haydu LE, Quinn MJ, Scolyer RA, et al
    Melanoma of the Vulva and Vagina: Principles of Staging and Their Relevance to Management Based on a Clinicopathologic Analysis of 85 Cases.
    Ann Surg Oncol. 2014.
    PubMed     Text format     Abstract available


  72. HASSAN S, Petrella TM, Zhang T, Kamel-Reid S, et al
    Pathologic Complete Response to Intralesional Interleukin-2 Therapy Associated with Improved Survival in Melanoma Patients with In-Transit Disease.
    Ann Surg Oncol. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: